Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44

Cancer Research

Volumn 64, Issue 13, 2004, Pages 4569-4576

  Kim, Hyeong Rok ^a   Wheeler, Marie A ^a   Wilson, Christopher M ^a   Iida, Joji ^a   Eng, David ^a   Simpson, Melanie A ^b   McCarthy, James B ^a   Bullard, Kelli M ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c MMC 450 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIC ACID SYNTHASE 1; HYALURONIC ACID SYNTHASE 2; HYALURONIC ACID SYNTHASE 3; MATRIGEL; MEMBRANE ENZYME; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL CULTURE; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOASSAY; TUMOR GROWTH;

ANTIGENS, CD44; BINDING, COMPETITIVE; COLONIC NEOPLASMS; DNA, ANTISENSE; HUMANS; HYALURONIC ACID; NEOPLASM INVASIVENESS; TRANSFECTION;

EID: 3042738008     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0202     Document Type: Article

References (78)

1. Arai H, Kang K-Y, Sato H, et al. Significance of the quantification and demonstration of hyaluronic acid in tissue specimens for the diagnosis of pleural mesothelioma. Am Rev Resp Dis 1979;120:529-32.
2. Ropponen K, Tammi M, Parkkinen J, et al. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 1998;58:342-7.
3. Hopwood J, Dorfman A. Glycosaminglycan synthesis by Wilms' tumor. Pediatr Res 1978;12:52-6.
4. Auvinen P, Parkkinen J, Agren U, et al. Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer 1997;74:477-81.
5. Auvinen P, Tammi R, Parkkinen J, et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000;156:529-36.
6. Setala L, Tammi M, Tammi R, et al. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer 1999;79:1133-8.
7. Lovvorn H, Savani R, Ruchelli E, Cass D, Adzick N. Serum hyaluronan and its association with unfavorable histology and aggressiveness of heterotransplanted Wilms' tumor. J Pediatr Surg 2000;35:1070-8.
8. Menzel E, Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett 1998;131:3-11.
9. Toole B. Glycosaminoglycans in morphogenesis. In: E. Hay (ed.), Cell Biology of Extracellular Matrix. New York: Plenum Publishing Corp., 1981. p. 259-294.
10. West D, Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989;183:179-96.
11. Shyjan A, Heldin P, Butcher E, Yoshino T, Briskin M. Functional cloning of the cDNA for a human hyaluronan synthase. J Biol Chem 1996;271:23395-9.
12. Watanabe K, Yamaguchi Y. Molecular identification of a putative human hyaluronan synthase, J Biol Chem 1996;271:22945-8.
13. Spicer A, McDonald J. Characterization and molecular evolution of a vertebrate hyaluronan synthase. J Biol Chem 1998;273:1923-32.
14. Itano N, Sawai T, Yoshida M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999;274:25085-92.
15. Kosaki R, Watanabe K, Yamaguchi Y. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage independent growth and tumorigenicity. Cancer Res 1999;59:1141-5.
16. Itano N, Sawai T, Miyaishi O, Kimata K. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res 1999;59:2499-504.
17. Simpson M, Wilson C, Furcht L, Spicer A, Oegema T, McCarthy J. Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells. J Biol Chem 2002; 277:10050-7.
18. Simpson M, Wilson C, McCarthy J. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am J Pathol. 2002;161:849-57.
19. Bullard K, Kim, H-R, Wheeler M, et al. Hyaluronan synthase-3 is upregulated in metastatic colon carcinoma cells and manipulation of expression alters matrix retention and cellular growth. Int J Cancer 2003;107:739-46.
20. Passiniti A, Taylor R, Pili R, et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 1992;67:519-27.
21. Albini A, Iwamoto Y, Kleinman H, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3229-45.
22. Repesh L. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 1989;9:192-208.
23. Iida J, Pei D, Kang T, Simpson M, Herlyn M, McCarthy J. Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen. J Biol Chem 2001;276:18786-94.
24. Knutson J, Iida J, Fields G, McCarthy J. CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma migration on type IV collagen and invasion of basement membrane. Mol Biol Cell 1996;7:383-96.
25. Nakagawa T, Kubota T, Kabuto M, Kodera T. Hyaluronic acid facilitates glioma cell invasion in vitro. Anticancer Res 1996;16:2917-22.
26. Radotra B, McCormick D. Glioma invasion in vitro is mediated by CD44-hyaluronan interactions. J Pathol 1997;181:434-8.
27. Ahrens T, Assmann V, Fieber C, Termeer C, Herrlich P, Hofmann M, Simon J. CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. J Investig Dermatol 2001;116:93-101.
28. Assmann V, Gillett C, Poulsom R, Ryder K, Hart I, Hanby A. The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells. J Pathol 2001;195: 191-6.
29. Banerji S, Ni J, Wang S, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
30. Bono P, Rubin K, Higgins J, Hynes R. Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol Biol Cell 2001;12:891-900.
31. Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002;195:99-111.
32. Weigel J, Weigel P. Characterization of the recombinant rat 175-kDa hyaluronan receptor for endocytosis (HARE). J Biol Chem 2003;278:42802-11.
33. Falkowski M, Schledzewski K, Hansen B, Goerdt S. Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces. Histochem Cell Biol 2003;120:361-9.
34. Politz O, Gratchev A, McCourt P, et al. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002;362 (Pt. 2):144-64.
35. Toole B. Hyaluronan promotes the malignant phenotype. Glycobiology 2002;12: 37R-42R.
36. Knudson C. Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J Cell Biol 1993;120:825-34.
37. Knudson C, Toole B. Changes in the pericellular matrix during differentiation of limb bud mesoderm. Devel Biol 1985;112:308-18.
38. Lesley J, Trowbridge I. Genetic characterization of a polymorphic murine cell-surface glycoprotein. Immunogenetics 1982;15:313-20.
39. Trowbridge I, Lesley J, Schulte R, Hyman R, Trotter J. Biochemical characterization and cellular distribution of a polymorphic murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 1982;15:299-312.
40. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade P. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 1995;182:419-29.
41. Simpson M, Reiland J, Burger S, et al. Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone. J Biol Chem 2001;276:17949-57.
42. Asao T, Nakamura J, Shitara Y, et al. Loss of standard type of CD44 expression in invaded area as a good indicator of lymph node metastasis in colorectal carcinoma. Dis Colon Rectum 2000;43:1250-4.
43. Choi S, Takahashi K, Eto H, Yoon S, Tanabe K. CD44s expression in human colon carcinomas influences growth of liver metastases. Int J Cancer 2000;85:523-6.
44. Yamada Y, Itano N, Narimatsu H, et al. Receptor for hyaluronan-mediated motility and CD44 expression in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res 1999;90:987-92.
45. Wong K, Rubenthiran U, Jothy S. Motility of colon cancer cells: modulation by CD44 isoform expression. Exp Molec Pathol 2003;75:124-30.
46. Wang C, Tammi M, Guo H, Tammi R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 1996; 148:1861-9.
47. Gold P. The carcinoembryonic antigen (CEA): Discovery and three decades of study. Perspect Colon Rectal Surg 1996;9:1-47.
48. Moorehead R, Hoper M, McKelvey S. Assessment of ornithine decarboxylase activity in rectal mucosa as a marker for colorectal adenomas and carcinoma. Br J Surg 1987;74:364-5.
49. Narisawa T, Takahashi M, Niwa M, et al. Increased mucosal omithine decarboxylase activity in large bowel with multiple tumors, adenocarcinoma, and adenoma. Cancer 1989;63:1572-6.
50. Herrera-Gayol A, Jothy S. Effects of hyaluronan on the invasive properties of human breast cancer cells in vitro. Int J Exp Pathol 2001;82:193-200.
51. Monaghan M, Mulligan K, Gillespie H, et al. Epidermal growth factor up-regulates CD44-dependent astrocytoma invasion in vitro. J Pathol 2000;192:519-25.
52. Kobayashi H, Suzuki M, Kanayama N, Nishida T, Takigawa M, Terao T. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells. Int J Cancer 2002;102:379-89.
53. Heldin P, Laurent T, Heldin C. Effect of growth factors on hyaluronan synthesis in human fibroblasts. Biochem J 1989;258:919-22.
54. Suzuki M, Asplund T, Yamashita H, Heldin C, Heldin P. Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves the activation of protein kinase C. Biochem J 1995;817-21.
55. Elias J, Krol R, Freundlich B, Sampson P. Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin. J Clin Investig 1988;81:325-33.
56. Postlethwaite A, Smith G, Lachman L, et al. Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by interleukin 1. Induction of hyaluronic acid synthesis by natural and recombinant interleukin 1s and synthetic interleukin 1 beta peptide 163-171. J Clin Investig 1989;83:629-36.
57. Saya T, Sugiyama Y, Takahashi Y, et al. Hyaluronan synthase 3 regulates hyaluronan synthesis in cultured human keratinocytes. J Investig Dermatol 2002;118:43-48.
58. Liu N, Gao F, Han Z, Xu X, Underhill C, Zhang L. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res 2001;61:5207-14.
59. Li Y, Heldin P. Hyaluronan production increases the malignant properties of mesothelioma cells. Br J Cancer 2001;85:600-7.
60. Ghatak S, Misra S, Toole B. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002;277:38013-20.
61. Knudson W. Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion. Am J Pathol 1996;6:1721-6.
62. Brecht M, Mayer U, Schlosser E, Prehm P. Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J 1986;239:445-50.
63. Matuoka K, Namba M, Mitsui Y. Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction. J Cell Biol 1987;104:1105-15.
64. Itano N, Fukiko A, Sawai T, et al. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci USA 2002;99:3609-14.
65. Bourguignon L, Singleton P, Zhu H, Diedrich F. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem 2003;278:29420-34.
66. Franzmann E, Weed D, Civantos F, Goodwin W, Bourguignon L. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression. Otolaryngol Head Neck Surg 2001;124:426-32.
67. Lokeshwar V, Fregien N, Bourguignon L. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol 1994;126:1099-109.
68. Zhu D, Bourguignon L. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation. Cell Motil Cytoskeleton 1998;39:209-22.
69. Peterson R, Yu Q, Stamenkovic I, Toole B. Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites. Am J Pathol 2000;156:2159-67.
70. Kubens B, Zanker K. Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). Cancer Lett 1998;131:55-64.
71. Turley E, Austen L, Vandeligt K, Clary C. Hyaluronan and cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Biol Chem 1991;112:1041-7.
72. Carpenter P, Dao A. The role of hyaluronan in mesothelium-induced motility of ovarian carcinoma cells. Anticancer Res 2003;23:3985-90.
73. Bourguignon L, Zhu H, Shao L, Chen Y. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem 2001;276:7327-36.
74. Zoltan-Jones A, Huang L, Ghatak S, Toole B. Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem 2003;278:45801-10.
75. Park M-J, Kim M-S, Park I-C, et al. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res 2002;62:6318-22.
76. Zhang Y, Thant A, Machida K, et al. Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res 2002;62:3962-5.
77. Bourguignon L, Gunja-Smith Z, Iida N, et al. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 1998;176:206-15.
78. Witty J, McDonnell S, Newell K, et al. Modulation of Matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo Cancer Res 1994;54:4805-12.